HomeNewsBusinessLockdown Lust: 65% surge in sale of adult sex products

Lockdown Lust: 65% surge in sale of adult sex products

India’s appetite for sex toys spiked significantly during the coronavirus lockdown, according to the fourth edition of India Uncovered: Insightful Analysis of Sex Products’ Trends in India.

August 01, 2020 / 13:33 IST
Story continues below Advertisement

Ignore the virus, push aside the lockdown despair. Think 50 shades of Gray. More than 50 shades, actually. Because India’s appetite for adult sex products has spiked 65 percent post Covid-19 lockdown.

Male pumps, female massagers and lubricants are on top of the sex-need hierarchy with male strokers and pleasure rings rising high on the lust list, according to the fourth edition of India Uncovered: Insightful Analysis of Sex ProductsTrends in India, a report curated by ThatsPersonal.com, India’s leading sexual wellness destination.

Story continues below Advertisement

Shunga Collection

Maharashtra continues to top the state ranking for sale of sex products, followed by Karnataka and Tamil Nadu. Amongst cities, Mumbai remains the biggest buyer followed by Bengaluru and New Delhi. Lucknow has emerged as the top tier II city in purchase of sex products while Panipat, Shillong, Puducherry (Pondicherry) and Haridwar are some of the prominent Tier III cities.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show